Government
Jul. 30, 2003
In the Balance
Forum Column - By Norm Kjono - Should pharmaceutical companies widely distribute nonsmoked nicotine products that are highly addictive and inherently harmful to consumers? Would it be appropriate to statutorily exempt these manufacturers from liability? What would the probable effect of such actions be on the value of the $18 billion in tobacco-settlement bonds that the states have issued to investors?
&n...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In